ConductScience.org, home

Trial · NCT02267538

Dexmedetomidine and Delirium in Patients After Cardiac Surgery

NCT02267538, Phase 4, Completed, Peking University First Hospital; results first posted 2018-02-05

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Dexmedetomidine and Delirium in Patients After Cardiac Surgery. Trials, record NCT02267538. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02267538

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Dexmedetomidine and Delirium in Patients After Cardiac Surgery
NCT number
NCT02267538
Status
Completed
Phases
Phase 4
Enrollment
285 participants, actual
Lead sponsor
Peking University First Hospital
Conditions
Delirium, C.Surgical Procedure; Cardiac, Postoperative Complications
Interventions
dexmedetomidine hydrochloride for injection, 0.9% sodium chloride for injection
First posted
2014-10-17
Last updated
2018-03-05
Results first posted
2018-02-05

Source ClinicalTrials.gov

Registered outcomes7

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryIncidence of Postoperative DeliriumDuring the first five days after surgeryDelirium was assessed with the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) twice daily during the first five days after surgery.
SecondaryCognitive Functionon the sixth day after surgery, and on the 30th day after surgery
Cognitive function was assessed with the Mini Mental State Examination (MMSE) at baseline (the day before surgery) and on the sixth day after surgery, and with modified telephone interview for cognitive status (m-TICS) on the 30th day after surgery. The introduction of MMSE scale has been explained in the baseline part in the result section. The Telephone Interview for Cognitive Status-modified scale(m-TICS) is one of the most popular telephone interview-based screening instruments for mild cognitive impairment and dementia. It consists 11 items including wordlist memory, orientation, attention, repetition, conceptual knowledge and nonverbal praxis, which score ranges from 0 to 48, with higher scores indicating better cognitive function
SecondaryIncidence of Non-delirium Complications After SurgeryOccurrence of non-delirium complications will be monitored until 30 days after surgery.
Non-delirium complications was defined as any conditions other than delirium that occurred during the first 30 days after surgery and required therapeutic intervention.Complications listed here were not considered adverse events in this study.
OtherPain IntensityDuring the first five days after surgeryPain intensity was assessed daily at 8 am during the first five days after surgery with the Numeric Rating Scale (NRS, 0 = no pain, 10 = the worst possible pain).
OtherSubjective Sleep QualityDuring the first five days after surgerySubjective sleep quality was assessed daily at 8 am during the first five days after surgery with the Numeric Rating Scale (NRS, 0 = best sleep, 10 = the worst possible sleep).
OtherLength of Stay in the Intensive Care UnitFrom end of surgery until discharge from Intensive Care Unit or 30 days after surgeryResults was presented as median (95% confidence interval).
OtherLength of Stay in Hospital After SurgeryFrom end of surgery until discharge from hospital or 30 days after surgeryResults was presented as median (95% confidence interval).

Outcomes7

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYIncidence of Postoperative DeliriumDuring the first five days after surgeryParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYCognitive Functionon the sixth day after surgery, and on the 30th day after surgery
5 patients (3 in CTRL group and 2 in DEX group) did not complete the MMSE test on postoperative day 6;17 patients (12 in CTRL group and 5 in DEX group) did not complete the m-TICS test on postoperative day 30
units on a scaleMEDIAN
SECONDARYIncidence of Non-delirium Complications After SurgeryOccurrence of non-delirium complications will be monitored until 30 days after surgery.ParticipantsCOUNT_OF_PARTICIPANTS
OTHER_PRE_SPECIFIEDPain IntensityDuring the first five days after surgeryunits on a scaleMEDIAN
OTHER_PRE_SPECIFIEDSubjective Sleep QualityDuring the first five days after surgeryunits on a scaleMEDIAN
OTHER_PRE_SPECIFIEDLength of Stay in the Intensive Care UnitFrom end of surgery until discharge from Intensive Care Unit or 30 days after surgeryhoursMEDIAN
OTHER_PRE_SPECIFIEDLength of Stay in Hospital After SurgeryFrom end of surgery until discharge from hospital or 30 days after surgerydaysMEDIAN

Results by group56

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Incidence of Postoperative DeliriumDEX Group7Participants
Incidence of Postoperative DeliriumCTRL Group11Participants
Cognitive FunctionDEX GroupMMSE score on postoperative day 629Inter-Quartile Range 27 to 30units on a scale
Cognitive FunctionCTRL GroupMMSE score on postoperative day 629Inter-Quartile Range 27 to 30units on a scale
Cognitive FunctionDEX Groupm-TICS score on postoperative day 3034Inter-Quartile Range 32 to 37units on a scale
Cognitive FunctionCTRL Groupm-TICS score on postoperative day 3034Inter-Quartile Range 32 to 36units on a scale
Incidence of Non-delirium Complications After SurgeryDEX GroupStroke3Participants
Incidence of Non-delirium Complications After SurgeryCTRL GroupStroke3Participants
Incidence of Non-delirium Complications After SurgeryDEX GroupNew onset arrythmia42Participants
Incidence of Non-delirium Complications After SurgeryCTRL GroupNew onset arrythmia51Participants

Participant flow6

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDDEX Group142
Overall StudySTARTEDCTRL Group143
Overall StudyCOMPLETEDDEX Group142
Overall StudyCOMPLETEDCTRL Group143
Overall StudyNOT COMPLETEDDEX Group0
Overall StudyNOT COMPLETEDCTRL Group0

Adverse events8

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEvents
otherIntraoperative BradycardiaCardiac disordersDEX Group2114221
otherIntraoperative BradycardiaCardiac disordersCTRL Group1414314
otherIntraoperative HypotensionVascular disordersDEX Group1014210
otherIntraoperative HypotensionVascular disordersCTRL Group1014310
otherPostoperative BradycardiaCardiac disordersDEX Group21422
otherPostoperative BradycardiaCardiac disordersCTRL Group61436
otherPostoperative HypotensionVascular disordersDEX Group51425
otherPostoperative HypotensionVascular disordersCTRL Group1014310

Adverse event totals6

The totals the trial posted for each group.

TotalGroupAffectedAt risk
Total, all-cause mortalityDEX Group2142
Total, all-cause mortalityCTRL Group4143
Total, other adverse eventsDEX Group38142
Total, other adverse eventsCTRL Group40143
Total, serious adverse eventsDEX Group0142
Total, serious adverse eventsCTRL Group0143

Papers49

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
1173044BACKGROUNDPubMed
2240918BACKGROUNDPubMed
9054252BACKGROUNDPubMed
11797025BACKGROUNDPubMed
12651650BACKGROUNDPubMed
14739805BACKGROUNDPubMed
15071384BACKGROUNDPubMed
15187514BACKGROUNDPubMed
15264710BACKGROUNDPubMed
15640638BACKGROUNDPubMed

1 to 10 of 49

See all 49 papers

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons3

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource
DEX Group vs CTRL Group: Incidence of Postoperative DeliriumTrial comparisons
DEX Group vs CTRL Group: deaths from any causeTrial comparisons
DEX Group vs CTRL Group: serious adverse eventsTrial comparisons

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT02267538

GET https://conductscience.org/api/trials/v1/NCT02267538/results?page=2